share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 27 02:21
Summary by Futu AI
Stuart A Arbuckle, an officer at Vertex Pharmaceuticals Inc, is set to sell 5,034 shares of common stock on 02/26/2024, with an aggregate market value of approximately $2,142,973.80. The shares to be sold were recently acquired on 02/24/2024 as compensation, with half being performance shares and the other half from restricted stock vesting, both sourced from the issuer. Over the past three months, Arbuckle has sold a total of 21,305 shares, generating gross proceeds of $8,778,640.27. The upcoming sale follows a pattern of recent transactions, indicating ongoing trading activity by the officer.
Stuart A Arbuckle, an officer at Vertex Pharmaceuticals Inc, is set to sell 5,034 shares of common stock on 02/26/2024, with an aggregate market value of approximately $2,142,973.80. The shares to be sold were recently acquired on 02/24/2024 as compensation, with half being performance shares and the other half from restricted stock vesting, both sourced from the issuer. Over the past three months, Arbuckle has sold a total of 21,305 shares, generating gross proceeds of $8,778,640.27. The upcoming sale follows a pattern of recent transactions, indicating ongoing trading activity by the officer.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.